AstraZeneca Ready to Scrap Plans for US Approval of COVID Shot
An AstraZeneca executive said the British drugmaker would consider not submitting its COVID-19 vaccine for approval in the United States if the regulatory process takes too long.
Reuters Health Information
source https://www.medscape.com/viewarticle/970480?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/970480?src=rss
Comments
Post a Comment